DaVita Inc.
DVA
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
PRNewsWire • 1 day ago • DVA
DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement
Zacks Investment Research • 1 day ago • DVA
DaVita HealthCare (DVA) Beats Stock Market Upswing: What Investors Need to Know
Zacks Investment Research • 2 days ago • DVA
4 Outpatient Home Health Stocks Gaining Attention Amid Market Shifts
GlobeNewsWire • 2 days ago • DVA
R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease
Zacks Investment Research • 3 days ago • DVA
4 Stocks Trading Near 52-Week Highs With Room to Rise Further
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.